Publication date: December 2026 Source: Sleep Medicine Reviews, Volume 90 Author(s): Alisson M. Paredes Naveda, Henrique Nunes Pereira Oliva, Alejandra Pulido-Saavedra, Delaram J. Ghadimi, James T. Lemmon, Peter T. Morgan, Marc N. Potenza, Gustavo A. Angarita
Corrigendum to “Actigraphy-based sleep outcomes in substance use disorders: A systematic review and meta-analysis” [Sleep Med Rev 88, 102297]. // Sleep Medicine Reviews. – URL: https://www.sciencedirect.com/science/article/pii/S108707922600153X?dgcid=rss_sd_all
Corrigendum to “Actigraphy-based sleep outcomes in substance use disorders: A systematic review and meta-analysis” [Sleep Med Rev 88, 102297]. Sleep Medicine Reviews. https://www.sciencedirect.com/science/article/pii/S108707922600153X?dgcid=rss_sd_all
“Corrigendum to “Actigraphy-based sleep outcomes in substance use disorders: A systematic review and meta-analysis” [Sleep Med Rev 88, 102297].” Sleep Medicine Reviews.
@article{article66237,
title = {Corrigendum to “Actigraphy-based sleep outcomes in substance use disorders: A systematic review and meta-analysis” [Sleep Med Rev 88, 102297]},
journal = {Sleep Medicine Reviews},
url = {https://www.sciencedirect.com/science/article/pii/S108707922600153X?dgcid=rss_sd_all}
}
ABSTRACT Introduction/Aims Pompe disease is a genetic myopathy caused by acid alpha‐glucosidase enzyme deficiency. Treatment response is mainly evaluated using motor scores, for instance the 6‐min walk test (6MWT) or the Motor Function...
ABSTRACT Introduction/Aims Inflammatory neuropathies (IN), such as Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune...